Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer

Anticancer therapies currently used in the clinic often can neither eradicate the tumor nor prevent disease recurrence due to tumor resistance. In this study, we showed that chemoresistance to pemetrexed, a multi-target anti-folate (MTA) chemotherapeutic agent for non-small cell lung cancer (NSCLC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, S-Q, Marti, T M, Dorn, P, Froment, L, Hall, S R R, Berezowska, S, Kocher, G, Schmid, R A, Peng, R-W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650740/
https://www.ncbi.nlm.nih.gov/pubmed/26181204
http://dx.doi.org/10.1038/cddis.2015.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650740/
https://www.ncbi.nlm.nih.gov/pubmed/26181204
http://dx.doi.org/10.1038/cddis.2015.195

Ejemplares similares